| Net loss | -3.3M |
| Depreciation | 664K |
| Compensation related to stock-based awards | |
| Provision for bad debts | -22K |
| Provision for excess and obsolete inventory | 407K |
| Accounts receivable | 5.41M |
| Inventories | -729K |
| Prepaid expenses and other current assets | 614K |
| Accounts payable | -1.77M |
| Accrued liabilities and deferred rent | -253K |
| Deferred revenue | 2.8M |
| Net cash provided by operating activities | |
| Purchase of property and equipment | -582K |
| Net cash used in investing activities | |
| Proceeds from issuance of common stock | |
| Proceeds from issuance of common stock - exercise of options | 0 |
| Proceeds from issuance of common stock - exercise of warrants | |
| Cash paid for fractional shares | |
| Proceeds from line of credit | |
| Payments on line of credit | |
| Payments on notes payable | |
| Net cash provided by financing activities | |
| Effect of exchange rates on cash and cash equivalents | 556K |
| Net increase in cash and cash equivalents | 5.18M |
| Cash and cash equivalents, beginning of period | 17.94M |
| Cash and cash equivalents, end of period | 23.11M |